Skip to content
Search

Latest Stories

E-pharmacy: Tracing its trend

Growing number of internet users leading to the higher adoption of digital technologies will offer unprecedented growth opportunities to e-pharmacy, analysts say...

E-pharmacy, a digital platform also known as internet pharmacy or online pharmacy, has emerged as an escape route to longstanding queues at pharmacy stores across almost all regions of the world, especially during the Covid-19 health crisis realm.


They have long been recognized to act promptly in public health response, like ensuring an effective medicine supply system, resolving and monitoring drug shortage issues, educating about the proper use of PPE, promoting remote pharmacy services, and conducting drug evaluation and active surveillance.

These factors will support in easing the load on healthcare facilities during the ongoing pandemic, eventually adding value to patients and the healthcare system.

Overall, the e-pharmacy market size is expanding in terms of valuation on the back of regulations and standards laid by the respective governments.

As per a recent study by Global Market Insights, the global e-pharmacy industry accounted for a business share of $68 billion in 2021 with an anticipated growth rate of 16.8 per cent through 2028.

Enlisted are some of the prominent countries/regions where e-pharmacies are gaining significant attention compared to conventional bricks-and-mortar pharmacy stores:

Europe

Europe, inclusive of the United Kingdom and Germany, is slated to cement its position as one of the hotspots for e-pharmacy industry with the growing population inclined towards online mode of medicine purchase.

Consider the following pointers:

  • More than two million people in the United Kingdom buy medicines regularly over the internet from some legitimate e-pharmacies.
  • Approximately 50 per cent of German shoppers prefer online pharmacies over brick-and-mortar ones, with the count only increasing post-Covid and social distancing mandates.

With the demand for online medications and doorstep delivery of these continuing to expand profusely, different healthcare and beauty retailers are striving to enter the online pharmacy business with strategic moves like acquisitions and mergers.

For instance, a German-based beauty retailer Douglas announced a breakthrough in online pharmacy through the acquisition of Disapo -- an e-pharmacy.

Reports suggest that the German retailer would integrate Disapo into its own digital platform, offering its customers proper access to the online pharmacy, initially in Germany.

North America

The burden of health diseases like common flu, cough, back pain, and others is substantially increasing in the United States and Canada.

This has led to an intrinsic demand for related over-the-counter products with access and dependence on e-pharmacy gradually rising.

Moreover, increasing internet penetration and growing number of e-commerce sites dealing with prescription drugs would support the expansion of e-pharmacy market in the region.

According to the National Association of Boards of Pharmacy estimates, there are nearly 400 websites dispensing prescriptions in the United States.

To support the surging demand for drugs through online portals, different companies are working relentlessly to foray into the new healthcare trend.

One of these companies is Amazon.

The tech giant, in 2020, marked a debut in the healthcare sector with the launch of its own online pharmacy service in the States. The online pharmacy would enable consumers to manage prescriptions, with Prime members to receive two-day deliveries on orders for medications.

Asia Pacific

It would be imperative to note that e-pharmacies are gradually taking up a major stake in the overall pharma retail value chain in various emerging APAC countries.

Having said that, the regional e-pharmacy market captured a revenue share of 17 per cent in the overall industry in the yesteryear, with China and India being the prominent geographies supporting the market expansion.

The growth of e-pharmacy industry in India can be credited to the growing internet penetration, changing customer preferences, and introduction of government initiatives that help augment the pharmaceutical industry canvas nationwide.

Constant innovations by leading market players to grab a prominent position in the region would well augment the growth curve in the coming years.

In 2021, Mumbai-based PharmEasy announced the acquisition of Medlife for an undisclosed amount to solidify its position as an e-pharmacy leader in the country.

Source: Global Market Insights Inc.

More For You

How to leverage data to drive pharmacy growth

Adele Curran, chief operating officer at Real World Analytics (RWA) Pharmacy.

Pharmacy challenges: How data can help spot the ‘elephant in the room’

Adopting new technologies is vital for moving pharmacy forward — but are you fully harnessing the data these tools generate?

“Being able to utilise, manage, and interpret the data these technologies provide can help add more value to your business,” said Adele Curran, chief operating officer at Real World Analytics (RWA) Pharmacy, while speaking at the recent Pharmacy Business Conference.

Keep ReadingShow less
Branded OTC products can boost pharmacy revenue and promote self-care, says PAGB CEO

Michelle Riddalls

How branded OTC products can help struggling community pharmacies - PAGB chief explains

Branded over-the-counter (OTC) products could play a vital role in promoting self-care and supporting the sustainability of community pharmacies, said Michelle Riddalls, CEO of PAGB – the consumer healthcare association – during the recent Pharmacy Business Conference.

Riddalls emphasised that OTC medicines not only enable consumers to better manage their health through self-care but also offer pharmacies an opportunity to increase revenue, particularly during a time of mounting financial pressure.

Keep ReadingShow less
How Peptides Are Transforming Modern Drug Development

Modern Drug Development

How Peptides Are Transforming Modern Drug Development

The pharmaceutical industry is rapidly evolving, embracing new technologies and methodologies. Peptides are emerging as a crucial component in this transformation, offering innovative solutions to drug development. This shift is not only reshaping how drugs are discovered but also enhancing their efficacy and safety.

In recent years, the pharmaceutical landscape has undergone significant changes, driven by advancements in technology and scientific understanding. One of the most promising areas of innovation is the use of peptides in drug development. These short chains of amino acids have proven to be versatile tools, capable of targeting specific cells or molecules with high precision. In this context, certain bpc 157 peptide research peptides have been highlighted for their potential applications in various therapeutic areas, showcasing the promise that peptides hold for modern pharmaceutical studies.

Keep ReadingShow less
Off-patent medicines could save NHS millions—but only if UK remains attractive to suppliers - BGMA

BGMA chief executive Mark Samuels urges government to back off-patent medicines ahead of Life Sciences Plan release.

UK risks losing millions in NHS savings without stronger support for generics - BGMA

The British Generic Manufacturers Association (BGMA) has called on the government to create a more supportive environment for the generics and biosimilars sector, warning that the UK risks missing out on significant NHS savings arising from new off-patent medicines.

According to the BGMA, 31 medicines are due to lose patent protection between January and June 2025, with a further 28 set to follow in the second half of the year.

Keep ReadingShow less
Support for generic medicines manufacturers key to affordable healthcare- Teva UK director

Teva UK sounds alarm on accelerating consolidation of critical generic medicines

Photo credit: gettyimages

Exclusive: Teva UK calls for inclusion of generic manufacturers in policy talks

A healthy and vibrant generics marketplace supports not only patients but also contributes billions of pounds in savings to the drugs bill. However, growing pressures on generic medicine manufacturers could threaten this vital part of the healthcare ecosystem, warns Ryan Ruscoe, senior director of generics and OTC at Teva UK.

Speaking exclusively to Pharmacy Business, Ruscoe stressed the urgent need to address supply chain vulnerabilities, particularly for critical generic medicines.

Keep ReadingShow less